CAS: 482-38-2; 5-Hydroxy-2-(4-Hydroxyphenyl)-3,7-Bis(((2S,3R,4R,5R,6S)-3,4,5-Trihydroxy-6-Methyltetrahydro-2H-Pyran-2-yl)Oxy)-4H-Chromen-4-One

该化合物是复合植物家族中,其结构特征是五氯酚基质,与糖味,典型的甘蔗或甘蔗糖有关,通常为香糖或葡萄糖.该化合物展示了一系列生物活动,包括抗氧化剂,抗炎剂和潜在的抗微生物特性,使其在药理学和营养研究中都具有意义. Kaempferitrin经常因其在传统医学中的作用及其潜在的治疗用途而受到研究.从物理性质来看,它一般是黄或褐色固态,在极地溶剂中可溶解,并可能表现出紫色吸收特性.其稳定性和再活性可能受到光和pH等环境因素的影响.

结构式图片

上下游产品

CAS号1374991-37-3 (2S,3R,4R,5S,6S... | CAS号55317-02-7 2-甲氧基-1-(2,4,6-... | CAS号108-73-6 间苯三酚 | CAS号1254191-99-5 3,7-di-O-benzyl... | CAS号482-39-3 阿福豆苷 | CAS号520-18-3 山奈酚 | CAS号3615-41-6 α-鼠李糖 | CAS号6014-42-2 鼠李糖 | CAS号14917-55-6 甲基α-L-吡喃鼠李糖苷 | CAS号73-34-7 6-methyloxane-2...

合成工艺路线路线简述

    📜山奈酚置于吡啶,甲醇,4-二甲氨基吡啶,三苯基膦双(三氟甲磺酰亚胺)金,Palladium 10% On Activated Carbon,三氟化硼乙醚,氢气,Potassium Carbonate体系中,用 四氢呋喃,二氯甲烷,N,N-二甲基甲酰胺 作为反应溶剂,化学反应 2.0H,反应生成 山奈苷
    参考文献:Efficient Synthesis Of Kaempferol 3,7-O-Bisglycosides Via Successive Glycosylation With Glycosyl Ortho-Alkynylbenzoates And Trifluoroacetimidates
    标题:Efficient Synthesis Of Kaempferol 3,7-O-Bisglycosides Via Successive Glycosylation With Glycosyl Ortho-Alkynylbenzoates And Trifluoroacetimidates
    摘要:Selective Glycosylation Of The 3-Oh Of 5,4'-Di-O-Acetyl-Kaempferol Was Achieved With Glycosyl Orthoalkynylbenzoates As Donors Under The Catalysis Of Ph(3)Palintf(2),And Subsequent Glycosylation Of The Remaining 7-Oh With Glycosyl Trifluoroacetimidates Under The Catalysis Of Bf3.Oet2,After Global Deprotection,Afforded The Kaempferol 3,7-O-Bisglycosides Conveniently. (C) 2012 Elsevier Ltd. All Rights Reserved.
    DOI:10.1016/j.Tetlet.2012.03.103

    专利信息


    专利号:US-12036300-B2
    优先权日:2021-03-31
    标题:Methods and compositions for improving skin
    发明人:LIAO I-CHIEN; BRIEVA PATRICIA; JUCHAUX FRANCK; BOUEZ CHARBEL; ZHENG QIAN; QIAN KUN
    权利人:OREAL
    摘要:A method for managing skin tone comprising reducing the synthesis of melanin by applying a skin treatment composition to skin. The skin treatment composition may include about 0.1 to about 25 wt. % of acetyl trifluoromethylphenyl valylglycine; about 0.5 to about 30 wt. % of a polyol; about 0.1 to about 30 wt. % of a silicone, fatty compound, or a mixtures thereof, wherein the skin treatment composition is an emulsion, and all weight percentages are based on the total weight of the skin treatment composition.

    专利号:EP-1493431-B1
    优先权日:2003-07-03
    标题:Use of an extract of bauhinia for the preparation of pharmaceutical and cosmetic compositions
    发明人:WIRTH CORINNA DR; BUCHHOLZ HERWIG DR
    权利人:MERCK PATENT GMBH
    摘要:Use of an aqueous or aqueous-alcoholic extract (A) of Bauhinia is claimed to make a composition for cosmetic or pharmaceutical treatment of skin and hair. Use of an aqueous or aqueous-alcoholic extract (A) of Bauhinia is claimed to make a composition for: (a) care, preservation or improvement of the general condition of the skin or hair; (b) prevention and/or inhibition of the aging process for human skin or hair; (c) for promoting healing of wounds; (d) for prevention and/or treatment of skin diseases associated with abnormal keratinization, and (e) for prevention and/or treatment of all malignant or benign growths of the dermis or epidermis. An independent claim is also included for a composition containing (A). ACTIVITY : Dermatological; Vulnerary; Antiseborrheic; Antipsoriatic; Cytostatic; Antiinflammatory; Virucide. MECHANISM OF ACTION : Protein glycosylation inhibitor. In a test, human fibroblasts were cultured in the presence of Vitamin C to stimulate collagen synthesis, then lysed and labeled with tritiated glucose for 15 days, Proteins were removed, extraction and precipitation were carried and the amount of bound glucose measured by liquid scintillation counting. Addition of an aqueous-alcoholic extract of Bauhinia fortificata (0.03 mg/ml), reduced protein glycosylation to 55% of that in a control.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Lambev I, Simeonova K, Sedmakova L, Krushkov I, Dimitrov D. [Therapeutic activity of nephroton, lespenefril and furosemide in experimental azotemia]. Eksp Med Morfol. 1985;24(4):27-35. Bulgarian. doi: 10.1007/s12272-014-0487-1. Epub 2014 Oct 15. doi: 10.1016/j.phymed.2015.09.003. Epub 2015 Oct 3. doi: 10.1104/pp.15.01780. Epub 2015 Nov 24.
    5: Puchalski Z, Kala E. [Clinical significance of lespenefril in modern therapy]. Wiad Lek. 1966 Sep 1;19(17):1333-6. Polish. doi: 10.3390/molecules191016987. doi: 10.1002/iub.1270. Epub 2014 May 10. doi: 10.3390/molecules191221442. doi: 10.1093/jxb/eru096. Epub 2014 Mar 11.
    10: Del Carmen Juárez-Vázquez M, Josabad Alonso-Castro A, García-Carrancá A. Kaempferitrin induces immunostimulatory effects in vitro. J Ethnopharmacol. 2013 Jun 21;148(1):337-40. doi: 10.1016/j.jep.2013.03.072. Epub 2013 Apr 12. doi: 10.1007/s00436-013-3600-3. Epub 2013 Sep 8. doi: 10.1016/j.ejphar.2013.02.029. Epub 2013 Mar 1. Review. doi: 10.1016/j.jep.2012.06.043. Epub 2012 Jul 20. doi: 10.1016/j.jep.2012.11.016. Epub 2012 Dec 2. Epub 2007 May 11. Chinese. Chinese. doi: 10.1002/ptr.3408. Epub 2011 Feb 10.

    合成参考文献


    摘要:Pharmaceutical Chemistry Journal, 19(326), 1985
    参考文献:10.1021/np030513u
    摘要:de Sousa E, Zanatta L, Seifriz I, Creczynski-Pasa TB, Pizzolatti MG, Szpoganicz B, Silva FRMB. Hypoglycemic Effect and Antioxidant Potential of Kaempferol-3,7-O-(α)-dirhamnoside from Bauhinia forficata Leaves. J. Nat. Prod. 2004 Apr 21;67(5):829–32. doi: 10.1021/np030513u.
    参考文献:10.1021/np50083a019
    摘要:Hu BH, Zhou LD, Liu YL. New tetrasaccharide flavonol glycoside from Epimedium acuminatum. J Nat Prod. 1992 May;55(5):672–5. doi: 10.1021/np50083a019.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知